192 related articles for article (PubMed ID: 32709845)
1. Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging.
Kauppi K; Rönnlund M; Nordin Adolfsson A; Pudas S; Adolfsson R
Transl Psychiatry; 2020 Jul; 10(1):250. PubMed ID: 32709845
[TBL] [Abstract][Full Text] [Related]
2. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
3. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
Sapkota S; Dixon RA
J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
[TBL] [Abstract][Full Text] [Related]
4. Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort.
Vasiljevic E; Koscik RL; Jonaitis E; Betthauser T; Johnson SC; Engelman CD
Alzheimers Dement; 2023 Jul; 19(7):3108-3118. PubMed ID: 36723444
[TBL] [Abstract][Full Text] [Related]
5. APOE ɛ4, but not polygenic Alzheimer's disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals.
Håglin S; Koch E; Schäfer Hackenhaar F; Nyberg L; Kauppi K
Sci Rep; 2023 May; 13(1):8433. PubMed ID: 37225733
[TBL] [Abstract][Full Text] [Related]
6. Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting.
Euesden J; Gowrisankar S; Qu AX; Jean PS; Hughes AR; Pulford DJ
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32370229
[No Abstract] [Full Text] [Related]
7. Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years.
Najar J; Thorvaldsson V; Kern S; Skoog J; Waern M; Zetterberg H; Blennow K; Skoog I; Zettergren A
Neurobiol Dis; 2023 Dec; 189():106357. PubMed ID: 37977433
[TBL] [Abstract][Full Text] [Related]
8. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
9. Genetic Stratification to Identify Risk Groups for Alzheimer's Disease.
Marioni RE; Campbell A; Hagenaars SP; Nagy R; Amador C; Hayward C; Porteous DJ; Visscher PM; Deary IJ
J Alzheimers Dis; 2017; 57(1):275-283. PubMed ID: 28222519
[TBL] [Abstract][Full Text] [Related]
10. Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging.
Supiyev A; Karlsson R; Wang Y; Koch E; Hägg S; Kauppi K
Neurobiol Aging; 2023 Jun; 126():103-112. PubMed ID: 36965205
[TBL] [Abstract][Full Text] [Related]
11. The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk.
Fan J; Tao W; Li X; Li H; Zhang J; Wei D; Chen Y; Zhang Z
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866553
[TBL] [Abstract][Full Text] [Related]
12. Genetic risk for Alzheimer's dementia predicts motor deficits through multi-omic systems in older adults.
Tasaki S; Gaiteri C; Petyuk VA; Blizinsky KD; De Jager PL; Buchman AS; Bennett DA
Transl Psychiatry; 2019 Oct; 9(1):241. PubMed ID: 31582723
[TBL] [Abstract][Full Text] [Related]
13. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain.
Felsky D; Patrick E; Schneider JA; Mostafavi S; Gaiteri C; Patsopoulos N; Bennett DA; De Jager PL
Mol Neurodegener; 2018 Jul; 13(1):38. PubMed ID: 30041668
[TBL] [Abstract][Full Text] [Related]
14. Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.
Andrews SJ; Das D; Anstey KJ; Easteal S
J Alzheimers Dis; 2017; 57(2):423-436. PubMed ID: 28269768
[TBL] [Abstract][Full Text] [Related]
15. Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics.
Sariya S; Felsky D; Reyes-Dumeyer D; Lali R; Lantigua RA; Vardarajan B; Jiménez-Velázquez IZ; Haines JL; Shellenberg GD; Pericak-Vance MA; Paré G; Mayeux R; Tosto G
Ann Neurol; 2021 Sep; 90(3):366-376. PubMed ID: 34038570
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
[No Abstract] [Full Text] [Related]
17. Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition.
Leonenko G; Shoai M; Bellou E; Sims R; Williams J; Hardy J; Escott-Price V;
Ann Neurol; 2019 Sep; 86(3):427-435. PubMed ID: 31199530
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E moderates the association between Non-
Xu Y; Sun Z; Jonaitis E; Deming Y; Lu Q; Johnson SC; Engelman CD
medRxiv; 2023 Jun; ():. PubMed ID: 37398140
[TBL] [Abstract][Full Text] [Related]
19. Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults.
Liebers DT; Pirooznia M; Seiffudin F; Musliner KL; Zandi PP; Goes FS
Schizophr Bull; 2016 Jul; 42(4):984-91. PubMed ID: 26873889
[TBL] [Abstract][Full Text] [Related]
20. Polygenic hazard scores in preclinical Alzheimer disease.
Tan CH; Hyman BT; Tan JJX; Hess CP; Dillon WP; Schellenberg GD; Besser LM; Kukull WA; Kauppi K; McEvoy LK; Andreassen OA; Dale AM; Fan CC; Desikan RS
Ann Neurol; 2017 Sep; 82(3):484-488. PubMed ID: 28940650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
